Home » Topics » Medical devices and technologies » Diagnostics

Diagnostics
RSS

Diatide products in clinical trials: Techtide P280 and P748

June 7, 1996

CDR-grafted type III anti-CEA MAbs identified

June 7, 1996

Potential hypoxic marker synthesized by Evanston Hospital

May 31, 1996

Biomira seeks NDS approval in Canada for Tru-Scint AD

May 31, 1996

Resolution Pharm. enters research agreement

May 31, 1996

Immunoassays for free prostate-specific antigen covered under U.S. patent

May 31, 1996

Eagle Research to license Oral-Assist products

May 24, 1996

Orphan drug status for CEA-Scan

May 24, 1996

Peptide Therapeutics, Dr. Fooke to research arthritis diagnostics

May 24, 1996

Isis claims oligonucleotides for diagnostic use

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.